Scientific Models & AI Platforms
- DeepMind
- AlphaFold 3 Molecular Interaction Prediction
- NVIDIA
- BioNeMo Biochemical Models
SCIENCE APPLICATIONS
Four Key Application Areas
Connect drug discovery, diagnostic testing, and multiomics biobanking with Science AI Agents and automation platforms.
01CORE MARKET 01 · AI DRUG DISCOVERY
The next opportunity in AI drug discovery:Autonomous Wet-lab Validation
AI greatly expands the search for molecular candidates. ESSENSE AI integrates Science AI Agents with Tecan platforms to help physical validation keep pace with AI output.
Major Pharmaceutical Companies
- Lilly
- Planning a dry-lab/wet-lab feedback loop with NVIDIA
- Novartis
- Collaborating with Isomorphic on drug design
AI Biotechnology Startups
- Isomorphic
- AI-driven Drug Design
- Recursion
- Automated wet-lab feedback to AI
Dry Lab · Virtual Prediction Engine
AI Drug Discovery: Virtual Prediction
Multiomics & experimental data → Target inference → Molecule generation → Candidate ranking
Candidate structures · Priorities · Experimental requirements →
ORCHESTRATOR
ESSENSE Science AI Agents
- Design Experiments
- Schedule Execution
- Quality Control
Scientists set objectives and review key decisions
← Successful & unsuccessful results · Model updates
Wet Lab · Physical Validation Engine
Autonomous Wet Lab: Physical Validation
Sample processing → Cellular / biochemical assays → Multiomics testing → Early toxicity assessment
Business opportunity: help validation capacity keep pace with AI-generated candidates—repeatable, high-throughput experiments that drive the next optimization cycle.
Sources: Google DeepMind / AlphaFold 3; NVIDIA + Lilly AI Lab; Isomorphic Labs; Recursion. Company examples illustrate industry activity.
02CORE MARKET 02 · ESSENSE × TECAN STRATEGIC COLLABORATION
Global NGS Diagnostics: Cancer Burden and Public Coverage Drive Testing Capacity
Demand for genetic and cancer genomic testing is growing across markets. Standardized preparation, quality management, and data traceability are essential to scaling.
New Cancer Cases Worldwide (IARC / WHO)
20 million2022
→35 million+2050 Projection
2022 → 2050 projection · Disease burden figures, not testing volumes
International Coverage Pathways Are Established
- US Medicare
- Coverage for qualifying cancer NGS tests
- UK NHS
- National Genomic Test Directory defines commissioned tests
Coverage varies by condition, test, and eligibility
Precision Oncology
Genetic variants & treatment decisions
Genetic Disorders / Hereditary Cancer
Risk assessment, diagnosis & family counseling
Requirements for Expansion Across Markets
Standardized processing & traceable quality control
ESSENSE Science AI Agents × NGS Diagnostic Laboratory Automation
- 01
Specimens
Barcode registration · Traceability
- 02
Fluent Library Preparation
Automated pipetting & library preparation
- 03
Robotic Handoff
Automated transfer between instruments
- 04
NGS Sequencing
Illumina NovaSeq X
- 05
AI Variant Analysis
Automated interpretation & quality control
- 06
Professional Review
Upload results according to requirements
ESSENSE Science AI Agents integrate Tecan automated liquid handling platforms and related equipment to build automated NGS diagnostic laboratories.
03CORE MARKET 03 · ESSENSE × WATERS × TECAN STRATEGIC COLLABORATION
Global Mass Spectrometry Testing: Emerging Substances and Precise Quantification Drive Automation
Rapid changes in emerging drugs and the growth of clinical quantitative assays are driving integrated LC-MS/MS preparation, testing, and quality control workflows.
UNODC Global Early Warning Advisory
1,500+ substancesNew psychoactive substances reported worldwide
As of August 2026 · Number of monitored substances, not testing volumes
EUDA Europe, 2025
50 substancesNew substances reported for the first time
Continual method updates increase demand for standardized testing
Toxicology Testing
Emergency & poisoning assessment
Drug Abuse Testing
Emerging substances & confirmatory analysis
Metabolites
Amino acid & steroid quantification
Therapeutic Drug Monitoring
Drug concentrations & dose adjustment
ESSENSE Science AI Agents × Automated LC-MS/MS Testing Workflow
- 01
Specimens
Barcode registration · Traceability
- 02
Fluent & Andrew+
Fluent 480 × Andrew+ Robot
- 03
Robotic Handoff
Automated transfer between instruments
- 04
LC-MS/MS
Xevo TQ Absolute
- 05
AI Peak Interpretation
Anomaly alerts & quality control
- 06
Professional Review
Approve & issue reports
ESSENSE Science AI Agents integrate Tecan automated liquid handling platforms and Waters mass spectrometers to build automated clinical mass spectrometry laboratories.
04CORE MARKET 04 · ESSENSE × TECAN STRATEGIC PARTNERSHIP
Global Biobanking: Million-person Cohorts Drive Autonomous Wet Labs
Population multiomics programs expand specimen processing and data integration needs. Standardization, automation, and AI coordination are key to scaling.
UK BIOBANK
500,000 peopleExisting Research CohortOUR FUTURE HEALTH
5 million peopleRecruitment TargetFrom Specimens to Data Assets for AI Training
- UK Biobank
- Plans to analyze 600,000 proteomic samples
- SG100K
- 100,000 participants and whole-genome sequencing
Specimen Receipt & Traceability
Barcode registration, identity checks & workflow records
High-throughput Aliquoting & Storage
Consistent processing, cold storage inventory & retrieval
Multiomics Data Integration
Link genomic, proteomic & clinical outcomes
ESSENSE Science AI Agents × Biobank Automation
- 01
Barcode Registration
Specimen identity & origin
- 02
Automated Aliquoting
Tecan Fluent
- 03
Storage & Inventory
Robotic Transfer
- 04
Multiomics Testing
Genomics & proteomics
- 05
AI Analysis & Quality Control
Anomaly alerts & human review
Opportunity: Turn global biobanking demand into scalable, auditable autonomous wet laboratories.
EXPLORE SCIENCE INTELLIGENCE
Turn Science AI into an actionable solution.
Discuss equipment, sample processing, methods, and integration requirements with ESSENSE AI to plan an autonomous laboratory for your needs.